0001566028-13-000030.txt : 20131008 0001566028-13-000030.hdr.sgml : 20131008 20131008171840 ACCESSION NUMBER: 0001566028-13-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131004 FILED AS OF DATE: 20131008 DATE AS OF CHANGE: 20131008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDWYN MARTIN M CENTRAL INDEX KEY: 0001186837 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20424 FILM NUMBER: 131141949 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-10-04 0000887497 HI TECH PHARMACAL CO INC HITK 0001186837 GOLDWYN MARTIN M C/O TASHLIK KREUTZER GOLDWYN & CRANDELL 40 CUTTERMILL ROAD GREAT NECK NY 11021 1 0 0 0 Common Stock 2013-10-04 4 M 0 1500 24.95 A 1500 D Common Stock 2013-10-04 4 S 0 1500 43.10 D 0 D Stock Option (Right to Buy) 24.95 2013-10-04 4 M 0 1500 0 D 2006-11-08 2015-11-08 Common Stock 1500 7875 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.08 to $43.16, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan. The option became exercisable in four equal annual installments beginning on the first anniversary of the grant date. Other than the option to acquire an additional 9,375 shares of the Company's stock reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 75,400 shares of the Company's stock (for options to acquire an aggregate of 84,775 shares). The other options were granted on various dates, with varying exercise prices and exercisable and expiration dates. Martin M. Goldwyn 2013-10-08